Santa Ana Bio

Targeted Therapies for Precision Immunology

Alameda, United States · Founded 2022 · $168.0M raised

Employees
11–50
Founded
2022
Business Model
B2B
Total Funding
$168.0M
Last Round
$43.0M Series AJun 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 5 investors for this company. The full record is or through the API.

About

Santa Ana Bio is a Bay Area biotechnology company developing a pipeline of precision immunology therapeutics by leveraging its proprietary multi-omics and protein engineering platforms. The company engineers antibody therapies for selective targeting and depletion of specific immune cells implicated in inflammatory and autoimmune diseases, aiming to unlock more precise treatments than broad immunosuppressants. Founded in 2022 and headquartered in Alameda, California, Santa Ana Bio launched with $168 million in funding backed by investors including Versant Ventures, GV, Andreessen Horowitz (a16z bio), and TPG Life Sciences Innovation, positioning it as a well-resourced entrant in the competitive precision biologics space.

Summary

Santa Ana Bio is an Artificial Intelligence company based in Alameda, United States, founded in 2022. It has raised $168.0M in total across 2 rounds, most recently a $43.0M Series A round in Jun 2024. Investors include GV, Versant Ventures and TPG (Growth/Rise).

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJun 2024
$43.0M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Santa Ana Bio on Indexed.vc
<a href="https://indexed.vc/companies/santa-ana-bio"><img src="https://indexed.vc/api/badge/company/santa-ana-bio" alt="Santa Ana Bio on Indexed.vc" width="260" height="76" /></a>